CDK2 and cancer: We used relatively new TAA in our mini-array approach, because there are others (for example, p62, p53, MUC, Imp1, Koc, c-myc, survivin, p16, cyclin B1, cyclin D1, and CDK2) that are associated with several types of cancer, such as breast, gastric, lung, and prostate [20,33,34,35].